These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 5343651)
1. [Epidemiological studies in groups of persons immunized with mumps vaccine. I. Use of the vaccine in communities with a high epidemic potential]. Copelovici Y; Strati I; Strulovici D Stud Cercet Inframicrobiol; 1969; 20(1):3-10. PubMed ID: 5343651 [No Abstract] [Full Text] [Related]
2. [Epidemiological studies in groups of persons immunized with mumps vaccine. II. Use of the vaccine in communities after outbreak of mumps]. Copelovici Y; Strati I; Strulovici D; Pricop E; Harasim T; Ionescu M Stud Cercet Inframicrobiol; 1969; 20(2):91-8. PubMed ID: 5343652 [No Abstract] [Full Text] [Related]
6. [Epidemic parotitis: etiology, epidemiology and prevention]. Crovari P G Mal Infett Parassit; 1969 Jun; 21(5):337-48. PubMed ID: 5364694 [No Abstract] [Full Text] [Related]
7. [Anti-mumps vaccination with a live attenuated vaccine in a children's collective]. Drouhet V; Celers J; Minvielle A Bull Acad Natl Med; 1970 Jun; 154(23):570-6. PubMed ID: 4922864 [No Abstract] [Full Text] [Related]
8. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)]. Chamot E; Toscani L; Egger P; Germann D; Bourquin C Rev Epidemiol Sante Publique; 1998 Mar; 46(2):100-7. PubMed ID: 9592852 [TBL] [Abstract][Full Text] [Related]
9. [Mumps epidemic in vaccinated children in West Switzerland]. Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835 [TBL] [Abstract][Full Text] [Related]
10. [Vaccination against epidemic parotitis]. Midulla M; Chiavelli S Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. Ong G; Goh KT; Ma S; Chew SK J Infect; 2005 Nov; 51(4):294-8. PubMed ID: 16291282 [TBL] [Abstract][Full Text] [Related]
12. Results of study of live antiparotitic vaccine and perspectives for the elimination of mumps as a mass infection. Kliachko NS; Shaposhnikova RP; Martysheva LN J Hyg Epidemiol Microbiol Immunol; 1967; 11(1):45-54. PubMed ID: 6070334 [No Abstract] [Full Text] [Related]
14. [Epidemics in vaccinated persons. Do adults need a mumps booster vaccination? (interview by Dr. Judith Neumaier)]. Mankertz A MMW Fortschr Med; 2008 Jun; 150(23):7. PubMed ID: 18578069 [No Abstract] [Full Text] [Related]
16. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Peltola H; Kulkarni PS; Kapre SV; Paunio M; Jadhav SS; Dhere RM Clin Infect Dis; 2007 Aug; 45(4):459-66. PubMed ID: 17638194 [TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization. Avijgan M; Habibian R; Kheiri S East Mediterr Health J; 2009; 15(2):295-301. PubMed ID: 19554975 [TBL] [Abstract][Full Text] [Related]
19. Use of attenuated live mumps virus vaccine during a "virgin soil" epidemic of mumps on St. Paul Island, Alaska. Maynard JE; Shramek G; Noble GR; Deinhardt F; Clark P Am J Epidemiol; 1970 Nov; 92(5):301-6. PubMed ID: 5473777 [No Abstract] [Full Text] [Related]
20. Epidemiologic effectiveness of intradermal inoculation with live vaccine against epidemic parotitis (mumps). Raikhshtat GN; Shapiro AA; Karaseva MF; Leikina RF; Ryumina MG; Berlovich EA Fed Proc Transl Suppl; 1966; 25(5):827-8. PubMed ID: 5223567 [No Abstract] [Full Text] [Related] [Next] [New Search]